Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PFIZER, INC.

(PFE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Pfizer : SVB Leerink Adjusts Pfizer PT to $50 From $49, Maintains Market Perform Rating

09/20/2021 | 08:10am EDT


© MT Newswires 2021
All news about PFIZER, INC.
07:32aPFIZER : United States Donates 1.4 Million More COVID-19 Pfizer Vaccines to Egypt Third Sh..
AQ
10/22Health Care Up On Defensive Bias -- Health Care Roundup
DJ
10/22PFIZER : says COVID-19 vaccine more than 90% effective in kids
AQ
10/22MODERNA : COVID SCIENCE-COVID-19 vaccines not linked to pregnancy loss; mixing vaccines ma..
RE
10/22Walmart, Walgreens U.S. stores roll out Moderna, J&J COVID-19 booster shots
RE
10/22EXPLAINER : Is it time to get a COVID-19 booster? Which one?
AQ
10/22PFIZER : FDA Panel to Vote on Pfizer COVID-19 Shots for Kids; Data Shows Vaccine 90.7% Eff..
MT
10/22PFIZER : says studies show COVID-19 vaccine over 90% effective in kids 5-11
AQ
10/22PFIZER : Norway Stops Second Dose COVID-19 Vaccine Inoculations For Minors
MT
10/22PFIZER : BioNTech COVID-19 Vaccine Shows Nearly 91% Efficacy in Kids
MT
More news
Analyst Recommendations on PFIZER, INC.
More recommendations
Financials (USD)
Sales 2021 81 557 M - -
Net income 2021 18 627 M - -
Net Debt 2021 29 307 M - -
P/E ratio 2021 12,7x
Yield 2021 3,66%
Capitalization 242 B 242 B -
EV / Sales 2021 3,33x
EV / Sales 2022 3,79x
Nbr of Employees 78 500
Free-Float 59,3%
Chart PFIZER, INC.
Duration : Period :
Pfizer, Inc. Technical Analysis Chart | PFE | US7170811035 | MarketScreener
Technical analysis trends PFIZER, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Last Close Price 43,16 $
Average target price 45,72 $
Spread / Average Target 5,94%
EPS Revisions
Managers and Directors
Albert Bourla Chairman, Chief Executive & Operating Officer
Frank A. D'Amelio Chief Financial Officer & EVP-Global Supply
Mikael Dolsten Chief Scientific Officer & Research President
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Aida Habtezion Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
PFIZER, INC.16.44%241 985
JOHNSON & JOHNSON4.03%430 990
ROCHE HOLDING AG15.15%337 974
NOVO NORDISK A/S58.77%242 392
ELI LILLY AND COMPANY44.37%220 979
MERCK & CO., INC.-0.79%205 421